Share.Market Logo

Accretion Pharmaceuticals Limited

  • Minimum Investment
    ₹1,15,200
  • Price Range
    ₹96 - ₹101
  • Issue Size
    ₹29.75 Cr
  • Lot Size
    1200 shares

This stock belongs to the SME (Small & Medium Enterprises) segment which usually has low liquidity and hence, is also riskier. It will be traded in a lot size of 2000 shares after listing.

Proceeds of this IPO to be used for

Capital expenditure towards the purchase of new equipment/machinery

Capital expenditure towards the upgradation of an existing manufacturing facility

Repayment/prepayment of certain borrowings availed by the company

Funding working capital requirements

General corporate purpose

Download RHP DocumentGet more in-depth details about this IPO.

Strengths & Weaknesses of Accretion Pharmaceuticals Limited

Product range

The company offers a wide variety of healthcare formulations, enabling it to serve a large customer base in both domestic and international markets. Its commitment to quality, competitive pricing, and continuous product expansion supports its reputation as a global manufacturer

Quality focus

The company prioritises delivering high-quality products by continuously improving its production processes. It holds ISO 9001:2015 and ISO 14001:2015 certifications, reflecting its commitment to quality and environmental standards, which helps attract both domestic and international customers

Strong relationships

The company maintains long-term relationships with clients and suppliers, backed by experienced leadership and a well-established supply chain. This has helped build goodwill and trust in the market

Export dependence

The company earns a major part of its revenue from exports, making it sensitive to global factors such as currency fluctuations, trade policies, and geopolitical risks. Any decline in export profitability, without offsetting growth in domestic sales, can reduce profit margins, affect reinvestment plans, and weaken long-term financial stability

Regulatory risk

The pharmaceutical sector is highly regulated, and the company must comply with multiple environmental, safety, and health laws. Non-compliance or delays in obtaining or renewing statutory licenses and approvals may result in fines, legal action, or shutdowns

Manufacturing risk

The company operates with a single manufacturing facility in Ahmedabad, Gujarat. Any disruption, such as machinery breakdown, power failure, natural disasters, or social unrest, could severely impact operations. A prolonged shutdown, labor disputes, or failure to comply with regulatory approvals may result in financial losses

Financials

Earnings Per Share

Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.

No Data

Balance Sheet

A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr)Y/Y Change
Total Current Assets--
Total Non-Current Assets--
Fixed assets--
Total assets--
Total Current Liabilities--
Total Non-Current Liabilities--
Total Capital Plus Liabilities--
Total Shareholder Funds--
Total Debt to Equity--

Cash Flow

The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr)Y/Y Change
Cash from Operating Activity--
Cash from Financing Activities--
Cash from Investing Activities--
Net Cash Flow--

About Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Ltd. was incorporated on November 29, 2023. The company manufactures and markets a variety of pharmaceutical products, including tablets, capsules, ointments, and oral liquids. The company also offers contract manufacturing and loan licensing services to corporate clients.
  • Promoter
    Vivek Ashok Kumar Patel
  • Promoter
    Harshad Nanubhai Rathod
  • Promoter
    Mayur Popatlal Sojitra
  • Promoter
    Hardik Mukundbhai Prajapati

Accretion Pharmaceuticals Limited IPO FAQs

What is Accretion Pharmaceuticals Limited IPO?

down-arrow
Accretion Pharmaceuticals Limited IPO refers to the initial public offering of shares by Accretion Pharmaceuticals Limited. It is a process by which the company offers its shares to the public for the first time, allowing individuals to become shareholders.

What is the issue size of Accretion Pharmaceuticals Limited IPO?

down-arrow
For Accretion Pharmaceuticals Limited IPO the issue size is ₹30 Cr. The issue size is the total value of the shares offered to the public. It represents the amount the company aims to raise through the IPO.

What is the minimum investment amount for the Accretion Pharmaceuticals Limited IPO?

down-arrow
For Accretion Pharmaceuticals Limited IPO the minimum investment is ₹1,15,200. The minimum investment for Accretion Pharmaceuticals Limited IPO is the smallest amount an individual can invest to participate in the offering. It is usually determined by the company and regulatory requirements.

What is the lot size of Accretion Pharmaceuticals Limited IPO?

down-arrow
For Accretion Pharmaceuticals Limited IPO the lot size is 1200 shares. The lot size of Accretion Pharmaceuticals Limited IPO refers to the number of shares that investors need to bid for and purchase in a single transaction. It is predetermined by the company and regulators.

How to apply for Accretion Pharmaceuticals Limited IPO on Share.Market?

down-arrow
To apply for Accretion Pharmaceuticals Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the Accretion Pharmaceuticals Limited IPO from the list and click on apply now. Place your bids or choose the Cut-off Price option. Enter your UPI ID and set up your mandate to place your application.

Can I pre-apply for Accretion Pharmaceuticals Limited IPO?

down-arrow
Yes, investors can often pre-apply for some of the IPOs. Pre-application allows individuals to express their interest in participating in the IPO before the official subscription period begins. To pre- apply for Accretion Pharmaceuticals Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the IPO from the list and click on pre-apply now. Once the IPO opens for subscription you can enter your UPI ID and set up your mandate to place your application.

How many days is the IPO application window open?

down-arrow
The IPO application window typically remains open for 3 days, starting from the date of the IPO opening. However, this duration can vary depending on the specific IPO and the regulatory requirements.

Till what time can I apply for an IPO on the last day on Share.Market?

down-arrow
You can apply for the IPO till 3 PM on the last day of application on Share.Market.

What is the allotment date of Accretion Pharmaceuticals Limited IPO?

down-arrow
For Accretion Pharmaceuticals Limited IPO the allotment date is May 19, 2025. The allotment date of Accretion Pharmaceuticals Limited IPO is the date on which shares are allocated to the successful bidders. It marks the distribution of shares to investors.

What are the open and close dates of Accretion Pharmaceuticals Limited IPO?

down-arrow
For Accretion Pharmaceuticals Limited IPO, the subscription opens on May 14, 2025 and closes on May 16, 2025. The open and close dates of an IPO indicate the period during which investors can submit their bids to participate in the offering.
Bidding Ongoing
-
Total Subscription
7.72x Oversubscribed
Trade
Bidding Ongoing
-
Total Subscription
7.72x Oversubscribed
Trade